New Delhi: The booster dose vaccine has been approved for the third phase of the trial in the country amid a spate of covid cases. The DCGA panel of experts has approved the further trial of the vaccine of Bharat Biotech, which can be given through the nose. The vaccine will be available in March after the trial. Meanwhile, Covid and Omicron cases are on the rise in the country. Maharashtra and Delhi have the highest number of covid cases reported.
